Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.6M Sell
122,095
-1,466
-1% -$325K 0.37% 62
2025
Q4
$28.2M Buy
123,561
+21,355
+21% +$4.86M 0.38% 59
2025
Q3
$23.7M Sell
102,206
-322
-0.3% -$65.6K 0.35% 56
2025
Q2
$19M Sell
102,528
-937
-0.9% -$174K 0.3% 64
2025
Q1
$21.7M Sell
103,465
-2,196
-2% -$427K 0.36% 58
2024
Q4
$18.8M Sell
105,661
-37,242
-26% -$6.85M 0.3% 66
2024
Q3
$28.2M Sell
142,903
-2,855
-2% -$533K 0.44% 51
2024
Q2
$25M Sell
145,758
-8,233
-5% -$1.36M 0.41% 52
2024
Q1
$28M Sell
153,991
-28,892
-16% -$4.98M 0.44% 55
2023
Q4
$28.3M Sell
182,883
-5,864
-3% -$855K 0.41% 59
2023
Q3
$28.1M Sell
188,747
-18,360
-9% -$2.7M 0.45% 53
2023
Q2
$27.9M Sell
207,107
-82
-0% -$12K 0.42% 59
2023
Q1
$33M Buy
207,189
+1,446
+0.7% +$221K 0.53% 48
2022
Q4
$33.3M Sell
205,743
-2,708
-1% -$415K 0.53% 48
2022
Q3
$28M Sell
208,451
-11,040
-5% -$1.58M 0.47% 54
2022
Q2
$33.6M Buy
219,491
+4,056
+2% +$620K 0.52% 50
2022
Q1
$34.9M Buy
215,435
+6,148
+3% +$893K 0.46% 54
2021
Q4
$28.3M Buy
209,287
+97,021
+86% +$11.5M 0.36% 70
2021
Q3
$12.1M Sell
112,266
-76,013
-40% -$8.69M 0.27% 90
2021
Q2
$21.2M Buy
188,279
+4,151
+2% +$468K 0.49% 52
2021
Q1
$19.9M Buy
184,128
+77,852
+73% +$8.33M 0.49% 52
2020
Q4
$11.4M Buy
106,276
+8,704
+9% +$836K 0.31% 79
2020
Q3
$9.58M Hold
97,572
0.3% 83
2020
Q2
$9.58M Buy
97,572
+72,759
+293% +$6.41M 0.3% 83
2020
Q1
$1.89M Sell
24,813
-2,201
-8% -$187K 0.07% 163
2019
Q4
$2.39M Sell
27,014
-348
-1% -$28.9K 0.07% 166
2019
Q3
$2.07K Sell
27,362
-28,209
-51% -$1.93M 0.05% 176
2019
Q2
$4.04K Sell
55,571
-5,422
-9% -$426K 0.1% 137
2019
Q1
$4.92M Sell
60,993
-35,528
-37% -$2.91M 0.15% 118
2018
Q4
$8.9K Sell
96,521
-3,011
-3% -$265K 0.27% 79
2018
Q3
$9.41M Sell
99,532
-142,547
-59% -$13.5M 0.28% 88
2018
Q2
$22.4M Buy
242,079
+19,136
+9% +$1.87M 0.71% 38
2018
Q1
$21.1M Buy
222,943
+2,849
+1% +$313K 0.68% 41
2017
Q4
$21.3M Buy
220,094
+19,293
+10% +$1.82M 0.69% 43
2017
Q3
$17.8M Buy
200,801
+79,920
+66% +$6.08M 0.61% 49
2017
Q2
$8.77M Buy
120,881
+71,326
+144% +$4.8M 0.31% 77
2017
Q1
$3.23M Sell
49,555
-917
-2% -$57.7K 0.11% 134
2016
Q4
$3.16M Sell
50,472
-411
-0.8% -$25.1K 0.12% 130
2016
Q3
$3.21M Sell
50,883
-631
-1% -$40.8K 0.13% 131
2016
Q2
$3.19M Sell
51,514
-2,088
-4% -$127K 0.13% 128
2016
Q1
$3.06M Sell
53,602
-14,811
-22% -$826K 0.13% 125
2015
Q4
$4.05M Sell
68,413
-4,147
-6% -$239K 0.18% 112
2015
Q3
$3.95M Buy
72,560
+1,726
+2% +$112K 0.23% 88
2015
Q2
$4.76K Buy
70,834
+29
+0% +$1.89K 0.22% 93
2015
Q1
$4.14K Sell
70,805
-431
-0.6% -$26K 0.19% 106
2014
Q4
$4.66M Sell
71,236
-2,631
-4% -$166K 0.21% 100
2014
Q3
$4.27K Sell
73,867
-1,688
-2% -$93.7K 0.21% 102
2014
Q2
$4.26M Sell
75,555
-3,346
-4% -$176K 0.2% 101
2014
Q1
$4.06M Sell
78,901
-2,124
-3% -$107K 0.23% 100
2013
Q4
$4.28K Sell
81,025
-4,230
-5% -$208K 0.23% 92
2013
Q3
$3.81K Sell
85,255
-2,904
-3% -$129K 0.22% 96
2013
Q2
$3.64K Buy
+88,159
New +$3.86M 0.21% 96

Other funds holding ABBV

UMB Bank's ABBV Position: Q1 2026 in Review

UMB Bank reduced its AbbVie (ABBV) stake by 1.2% in Q1 2026, selling an estimated $325K and leaving 122,095 shares worth $26.6M. The position accounts for 0.37% of the portfolio, ranked #62.

UMB Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.9M in Q1 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • UMB Bank held 122,095 shares of AbbVie worth $26.6M as of Q1 2026.
  • UMB Bank sold 1,466 AbbVie shares in Q1 2026, an estimated $325K.
  • AbbVie made up 0.37% of UMB Bank's portfolio in Q1 2026, its #62 holding.
  • UMB Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • UMB Bank's AbbVie position peaked at $34.9M in Q1 2022.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.